Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisomal testis enriched protein 1 (PXT1) is a small, noncanonical BH3-only protein of 51 amino acids, predominantly expressed in male germ cells, especially during the primary spermatocyte stage[1][2][3]. It is unique as the only known peroxisomal protein specifically expressed in male germ cells[1][2]. PXT1 contains a functional peroxisomal targeting signal (PTS1) and colocalizes with other peroxisomal proteins[1]. Functionally, PXT1 is proapoptotic, inducing cell death via its N-terminal BH3-like domain. Overexpression in mice leads to severe apoptosis in germ cells and results in male infertility. This proapoptotic activity is regulated through interaction with BAT3 (an apoptosis regulator), which can inhibit PXT1-induced apoptosis[1][3]. At present, PXT1 is not established as a therapeutic target, and there are no known drugs or biomarkers involving this molecule[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisomal testis enriched protein 1 (PXT1).